Table 4.
OHSS in High Risk-Women Following Kisspeptin-54 Trigger
| Early OHSS | Late OHSS | |||
|---|---|---|---|---|
| OHSS Symptomatology | ||||
| No. of patients screened by OHSS symptoms | n = 60 | n = 60 | ||
| ≥1 symptom potentially consistent with OHSS | 9 (15%) | 11 (18%) | ||
| No. of patients requiring medical intervention or hospitalization for OHSS | 0 | 0 | ||
| Sonographical screening | ||||
| No. of patients screened with pelvic ultrasound | n = 54 | n = 51 | ||
| Left |
Right |
Left |
Right |
|
| Mean ovarian volume (mls) | 45 (35) | 50 (32) | 16 (11) | 19 (15) |
| Max ovarian diameter (mm) | 47 (13) | 48 (12) | 36 (8) | 38 (10) |
| No. of patients with maximum ovarian diameter >5 cm | 35 (58%) | 13 (22%) | ||
| No. of patients with maximum ovarian diameter >8 cm | 7 (12%) | 9 (15%) | ||
| No. of patients with pleural effusion | 0 | 0 | ||
| No. of patients with free fluid in abdomen | 0 | 0 | ||
| No. of patients with fluid in POD/adnexa | 26 (43%) | 8 (13%) | ||
| Blood parameters | ||||
| No. of patients screened with blood analysis | n = 53 | n = 50 | ||
| No. of patients with hematocrit >45% | 0 | 0 | ||
| No. of patients with white cell count >15 × 109/L | 0 | 1 | ||
| No. of patients with ALT or AST >2 × ULN | 1 (2%) | 1 (2%) | ||
| No. of patients with total protein >80 g/L | 2 (3%) | 4 (7%) | ||
| No. of patient with creatinine >110 μmol/L | 0 | 0 | ||
| No. of patients with OHSSa | ||||
| Normal | 57 (95%) | 59 (98%) | ||
| Mild | 3 (5%) | 1 (2%) | ||
| Moderate | 0 | 0 | ||
| Severe | 0 | 0 | ||
| Critical | 0 | 0 | ||
Abbreviations: POD, Pouch of douglas; ALT, Alanine transaminase; ULN, Upper Limit of Normal.